Report Detail
Global Nonalcoholic Steatohepatitis Diagnostic Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4697425 |
- 21 May, 2026 |
- Global |
- 81 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Nonalcoholic Steatohepatitis Diagnostic market size was valued at US$ 1693 million in 2025 and is forecast to a readjusted size of US$ 2401 million by 2032 with a CAGR of 5.2% during review period.
Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is part of a group of conditions called nonalcoholic fatty liver disease.
The nonalcoholic steatohepatitis (NASH) diagnostic market is driven by the increasing prevalence of NASH and the growing awareness of the disease among healthcare providers and patients. NASH is a severe form of nonalcoholic fatty liver disease (NAFLD) characterized by liver inflammation and fibrosis, and it poses a significant global health burden. The rise in obesity rates, sedentary lifestyles, and unhealthy dietary habits contribute to the growing prevalence of NASH. Additionally, advancements in diagnostic technologies, such as non-invasive imaging techniques and blood biomarker assays, have improved early detection and accurate diagnosis of NASH. However, the market also faces challenges, including the lack of specific and validated diagnostic biomarkers for NASH, as well as the need for additional research and clinical validation to establish standardized diagnostic criteria. Moreover, the complex pathophysiology of NASH requires a multi-modal approach to diagnosis, making the development of comprehensive and cost-effective diagnostic strategies a challenge. To succeed in this market, companies must invest in research and development to identify reliable diagnostic biomarkers, collaborate with healthcare providers to improve disease awareness and diagnosis rates, and work towards developing integrated diagnostic algorithms to enhance NASH diagnosis and patient management.
This report is a detailed and comprehensive analysis for global Nonalcoholic Steatohepatitis Diagnostic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nonalcoholic Steatohepatitis Diagnostic market size and forecasts, in consumption value ($ Million), 2021-2032
Global Nonalcoholic Steatohepatitis Diagnostic market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Nonalcoholic Steatohepatitis Diagnostic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Nonalcoholic Steatohepatitis Diagnostic market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nonalcoholic Steatohepatitis Diagnostic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nonalcoholic Steatohepatitis Diagnostic market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Echosens, Prometheus Laboratories, GENFIT SA, Siemens Medical Solutions USA, Inc., BioPredictive S.A.S, Quest Diagnostics Incorporated., Meridian Bioscience, Inc., Laboratory Corporation of America Holdings, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Nonalcoholic Steatohepatitis Diagnostic market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Serum Biomarkers
Hepatic Fibrosis Biomarkers
Oxidative Stress Biomarkers
Apoptosis Biomarkers
Others
Market segment by Application
Pharma & CRO Industry
Hospitals
Academic Research Institutes
Others
Market segment by players, this report covers
Echosens
Prometheus Laboratories
GENFIT SA
Siemens Medical Solutions USA, Inc.
BioPredictive S.A.S
Quest Diagnostics Incorporated.
Meridian Bioscience, Inc.
Laboratory Corporation of America Holdings
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nonalcoholic Steatohepatitis Diagnostic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nonalcoholic Steatohepatitis Diagnostic, with revenue, gross margin, and global market share of Nonalcoholic Steatohepatitis Diagnostic from 2021 to 2026.
Chapter 3, the Nonalcoholic Steatohepatitis Diagnostic competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Nonalcoholic Steatohepatitis Diagnostic market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nonalcoholic Steatohepatitis Diagnostic.
Chapter 13, to describe Nonalcoholic Steatohepatitis Diagnostic research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Nonalcoholic Steatohepatitis Diagnostic by Type
- 1.3.1 Overview: Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Nonalcoholic Steatohepatitis Diagnostic Consumption Value Market Share by Type in 2025
- 1.3.3 Serum Biomarkers
- 1.3.4 Hepatic Fibrosis Biomarkers
- 1.3.5 Oxidative Stress Biomarkers
- 1.3.6 Apoptosis Biomarkers
- 1.3.7 Others
- 1.4 Global Nonalcoholic Steatohepatitis Diagnostic Market by Application
- 1.4.1 Overview: Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Pharma & CRO Industry
- 1.4.3 Hospitals
- 1.4.4 Academic Research Institutes
- 1.4.5 Others
- 1.5 Global Nonalcoholic Steatohepatitis Diagnostic Market Size & Forecast
- 1.6 Global Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast by Region
- 1.6.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Region, (2021-2032)
- 1.6.3 North America Nonalcoholic Steatohepatitis Diagnostic Market Size and Prospect (2021-2032)
- 1.6.4 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size and Prospect (2021-2032)
- 1.6.6 South America Nonalcoholic Steatohepatitis Diagnostic Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Echosens
- 2.1.1 Echosens Details
- 2.1.2 Echosens Major Business
- 2.1.3 Echosens Nonalcoholic Steatohepatitis Diagnostic Product and Solutions
- 2.1.4 Echosens Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Echosens Recent Developments and Future Plans
- 2.2 Prometheus Laboratories
- 2.2.1 Prometheus Laboratories Details
- 2.2.2 Prometheus Laboratories Major Business
- 2.2.3 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product and Solutions
- 2.2.4 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Prometheus Laboratories Recent Developments and Future Plans
- 2.3 GENFIT SA
- 2.3.1 GENFIT SA Details
- 2.3.2 GENFIT SA Major Business
- 2.3.3 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product and Solutions
- 2.3.4 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 GENFIT SA Recent Developments and Future Plans
- 2.4 Siemens Medical Solutions USA, Inc.
- 2.4.1 Siemens Medical Solutions USA, Inc. Details
- 2.4.2 Siemens Medical Solutions USA, Inc. Major Business
- 2.4.3 Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Product and Solutions
- 2.4.4 Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Siemens Medical Solutions USA, Inc. Recent Developments and Future Plans
- 2.5 BioPredictive S.A.S
- 2.5.1 BioPredictive S.A.S Details
- 2.5.2 BioPredictive S.A.S Major Business
- 2.5.3 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product and Solutions
- 2.5.4 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 BioPredictive S.A.S Recent Developments and Future Plans
- 2.6 Quest Diagnostics Incorporated.
- 2.6.1 Quest Diagnostics Incorporated. Details
- 2.6.2 Quest Diagnostics Incorporated. Major Business
- 2.6.3 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product and Solutions
- 2.6.4 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Quest Diagnostics Incorporated. Recent Developments and Future Plans
- 2.7 Meridian Bioscience, Inc.
- 2.7.1 Meridian Bioscience, Inc. Details
- 2.7.2 Meridian Bioscience, Inc. Major Business
- 2.7.3 Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Product and Solutions
- 2.7.4 Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Meridian Bioscience, Inc. Recent Developments and Future Plans
- 2.8 Laboratory Corporation of America Holdings
- 2.8.1 Laboratory Corporation of America Holdings Details
- 2.8.2 Laboratory Corporation of America Holdings Major Business
- 2.8.3 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product and Solutions
- 2.8.4 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Nonalcoholic Steatohepatitis Diagnostic Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Nonalcoholic Steatohepatitis Diagnostic by Company Revenue
- 3.2.2 Top 3 Nonalcoholic Steatohepatitis Diagnostic Players Market Share in 2025
- 3.2.3 Top 6 Nonalcoholic Steatohepatitis Diagnostic Players Market Share in 2025
- 3.3 Nonalcoholic Steatohepatitis Diagnostic Market: Overall Company Footprint Analysis
- 3.3.1 Nonalcoholic Steatohepatitis Diagnostic Market: Region Footprint
- 3.3.2 Nonalcoholic Steatohepatitis Diagnostic Market: Company Product Type Footprint
- 3.3.3 Nonalcoholic Steatohepatitis Diagnostic Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Nonalcoholic Steatohepatitis Diagnostic Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Nonalcoholic Steatohepatitis Diagnostic Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Type (2021-2032)
- 6.2 North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2021-2032)
- 6.3 North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country
- 6.3.1 North America Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Country (2021-2032)
- 6.3.2 United States Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 6.3.3 Canada Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Type (2021-2032)
- 7.2 Europe Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Application (2021-2032)
- 7.3 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Country
- 7.3.1 Europe Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Country (2021-2032)
- 7.3.2 Germany Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 7.3.3 France Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 7.3.5 Russia Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 7.3.6 Italy Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Region
- 8.3.1 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Region (2021-2032)
- 8.3.2 China Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 8.3.3 Japan Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 8.3.5 India Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 8.3.7 Australia Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Type (2021-2032)
- 9.2 South America Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Application (2021-2032)
- 9.3 South America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country
- 9.3.1 South America Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Country
- 10.3.1 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
- 10.3.4 UAE Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Nonalcoholic Steatohepatitis Diagnostic Market Drivers
- 11.2 Nonalcoholic Steatohepatitis Diagnostic Market Restraints
- 11.3 Nonalcoholic Steatohepatitis Diagnostic Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Nonalcoholic Steatohepatitis Diagnostic Industry Chain
- 12.2 Nonalcoholic Steatohepatitis Diagnostic Upstream Analysis
- 12.3 Nonalcoholic Steatohepatitis Diagnostic Midstream Analysis
- 12.4 Nonalcoholic Steatohepatitis Diagnostic Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Nonalcoholic Steatohepatitis Diagnostic. Industry analysis & Market Report on Nonalcoholic Steatohepatitis Diagnostic is a syndicated market report, published as Global Nonalcoholic Steatohepatitis Diagnostic Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Nonalcoholic Steatohepatitis Diagnostic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
